Description
Latin name
IMUNOFAN
release form
Nasal spray dosed clear, or slightly opalescent, colorless, or slightly yellowish liquid. A slight specific odor is allowed.
Packaging
In a plastic bottle with a dispensing device 8.5 ml in a pack of cardboard 1 bottle.
Indications
Prevention and treatment in adults and children over two years of age: Immunodeficiency and toxic conditions.
Chronic inflammatory diseases of various etiologies.
Contraindications
Hypersensitivity
Pregnancy complicated by rhesus conflict
Children under 2 years of age.
Use during pregnancy and lactation
Due to insufficient knowledge, it should be used with caution during pregnancy and lactation.
Composition
1 dose
immunofan 50 mcg
excipients: sodium chloride benzalkonium chloride glycine sodium edetate (trilon B) purified water
Dosage and Administration
Intranasally.
When using the bottle, keep it upright, spray up.
Remove the protective cap from the spray gun.
Before first use, fill the metering pump by pressing the wide bezel of the sprayer 3-4 times.
Insert the nebulizer into the nasal passage with the head upright.
Press the wide bezel of the spray gun once as far as it will go.
1 dose of the drug contains 50 mcg of immunofan. The daily dose should not exceed 200 mcg.
In the complex treatment of acute and chronic infectious and inflammatory diseases accompanied by symptoms of intoxication and immunodeficiency
Assign 1 dose (50 mcg) in each nasal passage 2 times a day, daily for 10-15 days.
For opportunistic infections (cytomegalovirus and herpetic infections, toxoplasmosis, chlamydia, pneumocystosis, cryptosporidiosis)
1 dose (50 mcg) in each nasal passage 2 times a day, daily, treatment 10-15 days. If necessary, the course may be repeated after 2-4 weeks.
In case of chronic viral hepatitis and chronic brucellosis
1 dose (50 mcg) in each nasal passage 1 time per day, daily, treatment course 10-15 days, to prevent relapse, repeated courses should be taken after 4-6 months.
In the treatment regimen for HIV-infected patients
1 dose (50 mcg) in each nasal passage 1 time per day, daily, for 10-15 days. If necessary, the course may be repeated after 2-4 weeks.
In the treatment of cancer patients in a radical combined treatment regimen (chemo-radiation therapy and surgery)
1 dose (50 mcg) in each nasal passage 1 time per day, daily,ia and surgery followed by the continuation of the course throughout the entire period of treatment.
In patients with a widespread tumor process (stage III-IV) of different localization in terms of complex or symptomatic therapy
1 dose (50 mcg) in each nasal passage 1 time per day, daily, for 8-10 days. If necessary and the presence of pronounced phenomena of toxicosis, a repeated course is recommended.
Side effects
Possibly: individual intolerance, allergic reactions.
Storage conditions
The product is stored in a dark place at 2 ° C to 10 ° C, out of the reach of children. It is not recommended to use the product after the expiry date stated on the package.
Shelf life
2 years.
Active ingredient
Arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine
Terms and conditions
prescription
dosage form
nasal spray
Possible product names
IMUNOFAN 50MKG / DOSE 40DOSE FLAK SPRAY NASAL
Imunofan 50mkg / dose Spray nasal dosing. 40 doses Fl. layer. X1 B M
IMUNOFAN SPRAY NAZ. 500MKG / ML 40DOZ
IMUNOFAN SPRAY NAZ. 50MKG / DOSE FL. 40DOSE
Imunofan nasal spray 50 mcg / dose, 40 doses
Bionoks, Russia
